S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
OTCMKTS:NMTC

NeuroOne Medical Technologies Stock Forecast, Price & News

$2.95
+0.02 (+0.68 %)
(As of 10/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.82
$2.98
50-Day Range
$2.91
$5.41
52-Week Range
$2.49
$13.50
Volume116,915 shs
Average Volume131,786 shs
Market Capitalization$35.40 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive NMTC News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuroOne Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.


NeuroOne Medical Technologies logo

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corp. operates as a medical technology company. It focuses on development and commercialization of thin film electrode technology for cEEG and sEEG recording, brain stimulation and ablation solutions for patients suffering from brain related disorders. The company was founded on August 20, 2009 and is headquartered in Eden Prairie, MN.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:NMTC
Employees
2,019
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$35.40 million
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.96 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












NeuroOne Medical Technologies (OTCMKTS:NMTC) Frequently Asked Questions

What stocks does MarketBeat like better than NeuroOne Medical Technologies?

Wall Street analysts have given NeuroOne Medical Technologies a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but NeuroOne Medical Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were NeuroOne Medical Technologies' earnings last quarter?

NeuroOne Medical Technologies Co. (OTCMKTS:NMTC) posted its quarterly earnings data on Friday, August, 13th. The company reported ($0.25) EPS for the quarter. The firm had revenue of $0.04 million for the quarter.
View NeuroOne Medical Technologies' earnings history
.

How has NeuroOne Medical Technologies' stock been impacted by COVID-19 (Coronavirus)?

NeuroOne Medical Technologies' stock was trading at $2.13 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, NMTC shares have increased by 38.5% and is now trading at $2.95.
View which stocks have been most impacted by COVID-19
.

Who are NeuroOne Medical Technologies' key executives?

NeuroOne Medical Technologies' management team includes the following people:
  • David A. Rosa, President, Chief Executive Officer & Director
  • Ronald W. McClurg, Chief Financial Officer
  • Steven Mertens, Chief Technology Officer
  • Mark Christenson, Director-Business Development
  • Hijaz Haris, Vice President-Marketing

What other stocks do shareholders of NeuroOne Medical Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NeuroOne Medical Technologies investors own include Allena Pharmaceuticals (ALNA), Capcom (CCOEY), Iterum Therapeutics (ITRM), Aeglea BioTherapeutics (AGLE), Applied Genetic Technologies (AGTC), Ampliphi Biosciences (APHB), Axsome Therapeutics (AXSM), CVS Health (CVS), (NINE) and NIO (NIO).

What is NeuroOne Medical Technologies' stock symbol?

NeuroOne Medical Technologies trades on the OTCMKTS under the ticker symbol "NMTC."

Who are NeuroOne Medical Technologies' major shareholders?

NeuroOne Medical Technologies' stock is owned by a variety of retail and institutional investors. Top institutional investors include Intersect Capital LLC (0.42%).
View institutional ownership trends for NeuroOne Medical Technologies
.

Which institutional investors are buying NeuroOne Medical Technologies stock?

NMTC stock was bought by a variety of institutional investors in the last quarter, including Intersect Capital LLC.
View insider buying and selling activity for NeuroOne Medical Technologies
or or view top insider-buying stocks.

How do I buy shares of NeuroOne Medical Technologies?

Shares of NMTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NeuroOne Medical Technologies' stock price today?

One share of NMTC stock can currently be purchased for approximately $2.95.

How much money does NeuroOne Medical Technologies make?

NeuroOne Medical Technologies has a market capitalization of $35.40 million.

How many employees does NeuroOne Medical Technologies have?

NeuroOne Medical Technologies employs 2,019 workers across the globe.

What is NeuroOne Medical Technologies' official website?

The official website for NeuroOne Medical Technologies is www.originalsourcemusic.com.

Where are NeuroOne Medical Technologies' headquarters?

NeuroOne Medical Technologies is headquartered at 10006 Liatris Ln, EDEN PRAIRIE, MN 55347-1210, United States.

How can I contact NeuroOne Medical Technologies?

NeuroOne Medical Technologies' mailing address is 10006 Liatris Ln, EDEN PRAIRIE, MN 55347-1210, United States. The company can be reached via phone at (952) 426-1383 or via email at [email protected].


This page was last updated on 10/23/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.